Tofisopam

규격

22345-47-7CAS 번호

244-922-3EC 번호

1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepineIUPAC 명칭

C22H26N2O4화학식

382.5 g/mol분자량

tofisopam; 22345-47-7; 1-(3,4-Dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine; Emandaxin; tofizopam; Tofisopamum; DTXSID3023681; UZC80HAU42; DTXCID303681; RefChem:898544; N05BA23; (5RS)-1-(3,4-Dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine; 244-922-3; Grandaxin; Egyt 341; MFCD00823171; 5H-2,3-Benzodiazepine, 1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-; 1-(3,4-Dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-benzo[d][1,2]diazepine; NCGC00165912-02; Seriel; benzodiazepine; EGYT 341; Grandaxin; Nodeprine; Seriel; Tofisopamum [INN-Latin]; Tofisopam [INN:DCF:JAN]; EINECS 244-922-3; UNII-UZC80HAU42; CCRIS 8738; Emandaxin (TN); 5H-2,3-Benzodiazepine, 1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-1-(3,4-Dimethoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5H-2,3-benzodiazepine; 7,8-Dimethoxy-1-(3,4-dimethoxyphenyl)-5-ethyl-4-methyl-5H-2,3-benzodiazepine; EGYT 341; Grandaxin; Seriel; Tofisopam; TOFISOPAM [INN]; TOFISOPAM [JAN]; TOFISOPAM [MI]; Tofisopam (JP18/INN); TOFISOPAM [MART.]; TOFISOPAM [WHO-DD]; SCHEMBL43522; CHEMBL404216; orb1304152; SCHEMBL8086894; SCHEMBL29832594; CHEBI:32241; HY-A0165; Tox21_112269; Tofisopam, >=98% (HPLC), solid; AKOS025401672; MSK15275-100M; DB08811; SB17495; SB17496; 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5H-2,3-benzodiazepine; 7,8-Dimethoxy-1-(3,4-dimethoxyphenyl)-5-ethyl-4-methyl-5H-2,3-benzodiazepine; NCGC00165912-01; NCGC00165912-03; AC-24288; FT167872; LS-14948; SY108258; Tofisopam Solution in Methanol, 100ug/mL; CAS-22345-47-7; DB-045872; NS00003139; D01254; T34896; F600994; Q945537; BRD-A69095630-001-01-1; 1-[3,4-bis(methyloxy)phenyl]-5-ethyl-4-methyl-7,8-bis(methyloxy)-5H-2,3-benzodiazepine; (+/-)-1-(3,4-DIMETHOXYPHENYL)-5-ETHYL-7,8-DIMETHOXY-4-METHYL-5H-2,3-BENZODIAZEPINE동의어